• About us
• Contact

Advertisement

Product › Details

drug discovery technology

	Next higher product group	drug discovery

Record changed: 2024-10-10

Advertisement

More documents for drug discovery technology

• [1] Veraxa Biotech AG. (4/23/25). "Press Release: Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies". Zürich & Brooklyn, NY....
• [2] FairJourney Biologics S.A.. (3/4/25). "Press Release: FairJourney Biologics Acquires Charles River Laboratories South San Francisco Facility". Porto & San Francisco, CA....
• [3] Nuclera Ltd.. (2/24/25). "Press Release: Nuclera Appoints Seth Benson as Chief Financial Officer". Cambridge....
• [4] Atrandi Biosciences. (2/19/25). "Press Release: Atrandi Biosciences Raises $25M Series A Led by Lux Capital to Drive the Future of Single-Cell Multiomics with Semi-Permeable Capsule Technology". Vilnius....
• [5] Nuclera Ltd.. (2/18/25). "Press Release: Nuclera Appoints William J. Kullback as Non-Executive Director". Cambridge....
• [6] Candid Therapeutics, Inc.. (1/13/25). "Press Release: Candid Therapeutics Enters into Agreement with WuXi Biologics on Trispecific T-cell Engager". New Brunswick, NJ & Bedminster, NJ....
• [7] Numab Therapeutics AG. (1/9/25). "Press Release: Numab Therapeutics Announces Series C Extension to CHF 180 Million, Completing Oversubscribed CHF 50 Million Financing". Horgen....
• [8] Ipsen S.A.. (12/3/24). "Press Release: Ipsen and Biomunex Announce Exclusive Global Licensing Agreement for First-in-Class MAIT Cell Engager in Immuno-oncology". Paris....
• [9] |transkript [Kääb, Georg]. (10/21/24). "Miltenyi Biotec: An Exclusive, Rare Interview with Founder Stefan Miltenyi. Interview by |transkript.de/Georg Kääb"....
• [10] Nuclera Ltd.. (10/16/24). "Press Release: Nuclera Closes $75 Million USD Financing > Series C round led by Elevage Medical Technologies". Cambridge & Boston, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.